TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $563,000 | -6.8% | 30,824 | -7.1% | 0.10% | -13.4% |
| Q4 2020 | $604,000 | -11.2% | 33,184 | -12.9% | 0.12% | -25.2% |
| Q3 2020 | $680,000 | -6.5% | 38,117 | -6.0% | 0.16% | -30.3% |
| Q2 2020 | $727,000 | +23.2% | 40,567 | +4.4% | 0.23% | +12.3% |
| Q1 2020 | $590,000 | -26.0% | 38,867 | -3.8% | 0.20% | -4.7% |
| Q4 2019 | $797,000 | +25.5% | 40,417 | +9.5% | 0.21% | +15.1% |
| Q3 2019 | $635,000 | +0.6% | 36,927 | +3.6% | 0.18% | +1.6% |
| Q2 2019 | $631,000 | -8.7% | 35,634 | +5.0% | 0.18% | -12.5% |
| Q1 2019 | $691,000 | – | 33,934 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |